While its safety profile was consistently favorable, the largest Phase IIb trial failed to show statistical significance for weight loss, and commercial development was halted in 2007.[2] Despite this, interest in AOD-9604 has continued in the compounding pharmacy and integrative medicine space, particularly given its safety data, its lack of IGF-1 stimulation, and emerging research around joint health
Third-Party Tested: Independent HPLC and mass spectrometry verification for every lot no exceptions
If FDA ultimately adds the two substances to the list, qualifying pharmacies would still need to source and identify the correct material, meet compounding requirements, and prepare a prescription for an identified patient
Answer: Our payment terms are T/T30% as a deposit, 70% before delivery
Learn more about Saccharomyces Ferment This ingredient comes from eggplant (or aubergine)
One user with 15-year patellar tendonitis reported dramatic initial improvement in the first two weeks, but then the progress drastically slowed despite experimenting with different doses and injection sites
